Skull Base Meningiomas in Patients with Neurofibromatosis Type 2: An International Multicenter Study Evaluating Stereotactic Radiosurgery
Status PubMed-not-MEDLINE Jazyk angličtina Země Německo Médium electronic-ecollection
Typ dokumentu časopisecké články
PubMed
35832959
PubMed Central
PMC9272243
DOI
10.1055/s-0041-1722937
PII: 200283
Knihovny.cz E-zdroje
- Klíčová slova
- gamma knife radiosurgery, meningioma, neurofibromatosis type 2, skull base,
- Publikační typ
- časopisecké články MeSH
Objective Meningiomas are the second most common tumors in neurofibromatosis type 2 (NF-2). Microsurgery is challenging in NF-2 patients presenting with skull base meningiomas due to the intrinsic risks and need for multiple interventions over time. We analyzed treatment outcomes and complications after primary Gamma Knife radiosurgery (GKRS) to delineate its role in the management of these tumors. Methods An international multicenter retrospective study approved by the International Radiosurgery Research Foundation was performed. NF-2 patients with at least one growing and/or symptomatic skull base meningioma and 6-month follow-up after primary GKRS were included. Clinical and radiosurgical parameters were recorded for analysis. Results In total, 22 NF-2 patients with 54 skull base meningiomas receiving GKRS as primary treatment met inclusion criteria. Median age at GKRS was 38 years (10-79 years). Most lesions were located in the posterior fossa (55.6%). Actuarial progression free survival (PFS) rates were 98.1% at 2 years and 90.0% at 5 and 10 years. The median follow-up time after initial GKRS was 5.0 years (0.6-25.5 years). Tumor volume at GKRS was a predictor of tumor control. Lesions >5.5 cc presented higher chances to progress after radiosurgery ( p = 0.043). Three patients (13.64%) developed adverse radiation effects. No malignant transformation or death due to meningioma or radiosurgery was reported. Conclusions GKRS is effective and safe in the management of skull base meningiomas in NF-2 patients. Tumor volume deserve greater relevance during clinical decision-making regarding the most appropriate time to treat. GKRS offers a minimally invasive approach of particular interest in this specific group of patients.
Department of Neurological Surgery House Ear Institute Los Angeles California United States
Department of Neurological Surgery Mayo Clinic Jacksonville Florida United States
Department of Neurological Surgery Na Homolce Hospital Prague Czech Republic
Department of Neurological Surgery University of Virginia Charlottesville Virginia United States
Department of Neurological Surgery West Virginia University Morgantown West Virginia United States
Department of Radiation Oncology Mayo Clinic Jacksonville Florida United States
Zobrazit více v PubMed
Asthagiri A R, Parry D M, Butman J Aet al.Neurofibromatosis type 2 Lancet 2009373(9679):1974–1986. PubMed PMC
Smith M J, Higgs J E, Bowers N L et al.Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset. J Med Genet. 2011;48(04):261–265. PubMed
Goutagny S, Kalamarides M. Meningiomas and neurofibromatosis. J Neurooncol. 2010;99(03):341–347. PubMed
Baser M E, Friedman J M, Aeschliman D et al.Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet. 2002;71(04):715–723. PubMed PMC
Desai R, Bruce J. Meningiomas of the cranial base. J Neurooncol. 1994;20(03):255–279. PubMed
Almefty R, Dunn I F, Pravdenkova S, Abolfotoh M, Al-Mefty O. True petroclival meningiomas: results of surgical management. J Neurosurg. 2014;120(01):40–51. PubMed
Gozal Y M, Alzhrani G, Abou-Al-Shaar H, Azab M A, Walsh M T, Couldwell W T. Outcomes of decompressive surgery for cavernous sinus meningiomas: long-term follow-up in 50 patients. J Neurosurg. 2020;132(02):380–387. PubMed
Ichinose T, Goto T, Ishibashi K, Takami T, Ohata K. The role of radical microsurgical resection in multimodal treatment for skull base meningioma. J Neurosurg. 2010;113(05):1072–1078. PubMed
Morisako H, Goto T, Ohata K. Petroclival meningiomas resected via a combined transpetrosal approach: surgical outcomes in 60 cases and a new scoring system for clinical evaluation. J Neurosurg. 2015;122(02):373–380. PubMed
Nanda A, Javalkar V, Banerjee A D. Petroclival meningiomas: study on outcomes, complications and recurrence rates. J Neurosurg. 2011;114(05):1268–1277. PubMed
Nanda A, Thakur J D, Sonig A, Missios S. Microsurgical resectability, outcomes, and tumor control in meningiomas occupying the cavernous sinus. J Neurosurg. 2016;125(02):378–392. PubMed
Singh N, Singh D K, Ahmad F, Kumar R. The retrosigmoid approach: workhorse for petroclival meningioma surgery. Asian J Neurosurg. 2019;14(01):188–192. PubMed PMC
Cohen-Inbar O, Lee C C, Schlesinger D, Xu Z, Sheehan J P. Long-term results of stereotactic radiosurgery for skull base meningiomas. Neurosurgery. 2016;79(01):58–68. PubMed
Sheehan J P, Williams B J, Yen C P. Stereotactic radiosurgery for WHO grade I meningiomas. J Neurooncol. 2010;99(03):407–416. PubMed
Patibandla M R, Lee C C, Sheehan J. Stereotactic radiosurgery of central skull base meningiomas-volumetric evaluation and long-term outcomes. World Neurosurg. 2017;108:176–184. PubMed
Starke R M, Nguyen J H, Reames D L, Rainey J, Sheehan J P. Gamma knife radiosurgery of meningiomas involving the foramen magnum. J Craniovertebr Junction Spine. 2010;1(01):23–28. PubMed PMC
Starke R M, Przybylowski C J, Sugoto M et al.Gamma knife radiosurgery of large skull base meningiomas. J Neurosurg. 2015;122(02):363–372. PubMed
Starke R M, Williams B J, Hiles C, Nguyen J H, Elsharkawy M Y, Sheehan J P. Gamma knife surgery for skull base meningiomas. J Neurosurg. 2012;116(03):588–597. PubMed
Goutagny S, Yang H W, Zucman-Rossi J et al.Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status. Clin Cancer Res. 2010;16(16):4155–4164. PubMed
Bi W L, Abedalthagafi M, Horowitz P et al.Genomic landscape of intracranial meningiomas. J Neurosurg. 2016;125(03):525–535. PubMed
Lee S, Karas P J, Hadley C C et al.The role of merlin/NF2 loss in meningioma biology. Cancers (Basel) 2019;11(11):E1633. PubMed PMC
Goutagny S, Bah A B, Henin D et al.Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features. Neuro-oncol. 2012;14(08):1090–1096. PubMed PMC
Walker A J, Ruzevick J, Malayeri A A et al.Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression? Future Oncol. 2014;10(07):1277–1297. PubMed PMC
Patibandla M R, Lee C C, Tata A, Addagada G C, Sheehan J P. Stereotactic radiosurgery for WHO grade I posterior fossa meningiomas: long-term outcomes with volumetric evaluation. J Neurosurg. 2018;129(05):1249–1259. PubMed
Mehta G U, Zenonos G, Patibandla M R et al.Outcomes of stereotactic radiosurgery for foramen magnum meningiomas: an international multicenter study. J Neurosurg. 2018;129(02):383–389. PubMed
Aboukais R, Zairi F, Baroncini Met al.Intracranial meningiomas and neurofibromatosis type 2 Acta Neurochir (Wien) 201315506997–1001., discussion 1001 PubMed
Li P, Wu T, Wang Y et al.Clinical features of newly developed NF2 intracranial meningiomas through comparative analysis of pediatric and adult patients. Clin Neurol Neurosurg. 2020;194:105799. PubMed
Evers S, Verbaan D, Sanchez E, Peerdeman S. 3D volumetric measurement of neurofibromatosis type 2-associated meningiomas: association between tumor location and growth rate. World Neurosurg. 2015;84(04):1062–1069. PubMed
Bassiouni H, Asgari S, Stolke D.Tuberculum sellae meningiomas: functional outcome in a consecutive series treated microsurgically Surg Neurol 2006660137–44., discussion 44–45 PubMed
D'Amico R S, Banu M A, Petridis P et al.Efficacy and outcomes of facial nerve-sparing treatment approach to cerebellopontine angle meningiomas. J Neurosurg. 2017;127(06):1231–1241. PubMed
Nanda A, Jawahar A, Sathyanarayana S. Microsurgery for potential radiosurgical skull base lesions: a retrospective analysis and comparison of results. Skull Base. 2003;13(03):131–138. PubMed PMC
Giammattei L, Starnoni D, Levivier M, Messerer M, Daniel R T. Surgery for clinoidal meningiomas: case series and meta-analysis of outcomes and complications. World Neurosurg. 2019;129:e700–e717. PubMed
Guduk M, Yener U, Sun H I, Hacihanefioglu M, Ozduman K, Pamir M N. Pterional and unifrontal approaches for the microsurgical resection of olfactory groove meningiomas: experience with 61 consecutive patients. Turk Neurosurg. 2017;27(05):707–715. PubMed
Goto T, Ohata K. Surgical resectability of skull base meningiomas. Neurol Med Chir (Tokyo) 2016;56(07):372–378. PubMed PMC
Aichholzer M, Bertalanffy A, Dietrich Wet al.Gamma knife radiosurgery of skull base meningiomas Acta Neurochir (Wien) 200014206647–652., discussion 652–653 PubMed
Bir S C, Ambekar S, Ward T, Nanda A. Outcomes and complications of gamma knife radiosurgery for skull base meningiomas. J Neurol Surg B Skull Base. 2014;75(06):397–401. PubMed PMC
Black P M, Villavicencio A T, Rhouddou C, Loeffler J S. Aggressive surgery and focal radiation in the management of meningiomas of the skull base: preservation of function with maintenance of local control. Acta Neurochir (Wien) 2001;143(06):555–562. PubMed
Couldwell W T, Cole C D, Al-Mefty O. Patterns of skull base meningioma progression after failed radiosurgery. J Neurosurg. 2007;106(01):30–35. PubMed
Eustacchio S, Trummer M, Fuchs I, Schröttner O, Sutter B, Pendl G. Preservation of cranial nerve function following gamma knife radiosurgery for benign skull base meningiomas: experience in 121 patients with follow-up of 5 to 9.8 years. Acta Neurochir Suppl (Wien) 2002;84:71–76. PubMed
Han J H, Kim D G, Chung H T et al.Gamma knife radiosurgery for skull base meningiomas: long-term radiologic and clinical outcome. Int J Radiat Oncol Biol Phys. 2008;72(05):1324–1332. PubMed
Hayashi M, Chernov M, Tamura N et al.Gamma knife robotic microradiosurgery for benign skull base meningiomas: tumor shrinkage may depend on the amount of radiation energy delivered per lesion volume (unit energy) Stereotact Funct Neurosurg. 2011;89(01):6–16. PubMed
Igaki H, Maruyama K, Koga T et al.Stereotactic radiosurgery for skull base meningioma. Neurol Med Chir (Tokyo) 2009;49(10):456–461. PubMed
Iwai Y, Yamanaka K, Ikeda H. Gamma knife radiosurgery for skull base meningioma: long-term results of low-dose treatment. J Neurosurg. 2008;109(05):804–810. PubMed
Iwai Y, Yamanaka K, Nakajima H, Yasui T, Kishi H. [Gamma knife radiosurgery for skull base meningiomas: the treatment results and patient satisfaction expressed in answers to a questionnaire] No Shinkei Geka. 2000;28(05):411–415. PubMed
Iwai Y, Yamanaka K, Shimohonji W, Ishibashi K. Staged gamma knife radiosurgery for large skull base meningiomas. Cureus. 2019;11(10):e6001. PubMed PMC
Joshi K C, Raghavan A, Muhsen B et al.Fractionated gamma knife radiosurgery for skull base meningiomas: a single-institution experience. Neurosurg Focus. 2019;46(06):E8. PubMed
Kreil W, Luggin J, Fuchs I, Weigl V, Eustacchio S, Papaefthymiou G. Long term experience of gamma knife radiosurgery for benign skull base meningiomas. J Neurol Neurosurg Psychiatry. 2005;76(10):1425–1430. PubMed PMC
Liscák R, Kollová A, Vladyka V, Simonová G, Novotný J., Jr Gamma knife radiosurgery of skull base meningiomas. Acta Neurochir Suppl (Wien) 2004;91:65–74. PubMed
Metellus P, Regis J, Muracciole Xet al.Evaluation of fractionated radiotherapy and gamma knife radiosurgery in cavernous sinus meningiomas: treatment strategy Neurosurgery 20055705873–886., discussion 873–886 PubMed
Morita A, Coffey R J, Foote R L, Schiff D, Gorman D. Risk of injury to cranial nerves after gamma knife radiosurgery for skull base meningiomas: experience in 88 patients. J Neurosurg. 1999;90(01):42–49. PubMed
Nakaya K, Chernov M, Kasuya Het al.Risk factors for regrowth of intracranial meningiomas after gamma knife radiosurgery: importance of the histopathological grade and MIB-1 index Minim Invasive Neurosurg 200952(5-6):216–221. PubMed
Nicolato A. 111Indium-octreotide brain scintigraphy: a prognostic factor in skull base meningiomas treated with gamma knife radiosurgery. Q J Nucl Med Mol Imaging. 2004;48(01):26–32. PubMed
Nicolato A, Ferraresi P, Foroni R et al.Gamma knife radiosurgery in skull base meningiomas. Preliminary experience with 50 cases. Stereotact Funct Neurosurg. 1996;66 01:112–120. PubMed
Nicolato A, Giorgetti P, Foroni Ret al.Gamma knife radiosurgery in skull base meningiomas: a possible relationship between somatostatin receptor decrease and early neurological improvement without tumour shrinkage at short-term imaging follow-up Acta Neurochir (Wien) 200514704367–374., discussion 374–375 PubMed
Park H R, Lee J M, Park K W et al.Fractionated gamma knife radiosurgery as initial treatment for large skull base meningioma. Exp Neurobiol. 2018;27(03):245–255. PubMed PMC
Pendl G, Eustacchio S, Unger F. Radiosurgery as alternative treatment for skull base meningiomas. J Clin Neurosci. 2001;8 01:12–14. PubMed
Pendl G, Schröttner O, Eustacchio S, Feichtinger K, Ganz J. Stereotactic radiosurgery of skull base meningiomas. Minim Invasive Neurosurg. 1997;40(03):87–90. PubMed
Pendl G, Schröttner O, Friehs G M, Feichtinger H. Stereotactic radiosurgery of skull base meningiomas. Stereotact Funct Neurosurg. 1995;64 01:11–18. PubMed
Pollock B E, Stafford S L, Link M J. Gamma knife radiosurgery for skull base meningiomas. Neurosurg Clin N Am. 2000;11(04):659–666. PubMed
Reynolds M R, Hawasli A H, Murphy R K et al.Acute hemorrhage following gamma knife radiosurgery to a clival meningioma. J Spine Neurosurg. 2013;2(02):108. PubMed PMC
Su C F, Liu D W, Lee C C, Chiu T L. Volume-staged gamma knife surgery for the treatment of large skull base meningioma surrounding the optical apparatus: a snowman-shape design. J Chin Med Assoc. 2017;80(11):697–704. PubMed
Takanashi M, Fukuoka S, Hojyo A, Sasaki T, Nakagawara J, Nakamura H. Gamma knife radiosurgery for skull-base meningiomas. Prog Neurol Surg. 2009;22:96–111. PubMed
Vermeulen S, Young R, Li F et al.A comparison of single fraction radiosurgery tumor control and toxicity in the treatment of basal and nonbasal meningiomas. Stereotact Funct Neurosurg. 1999;72 01:60–66. PubMed
Liu A, Kuhn E N, Lucas J T, Jr, Laxton A W, Tatter S B, Chan M D. Gamma knife radiosurgery for meningiomas in patients with neurofibromatosis Type 2. J Neurosurg. 2015;122(03):536–542. PubMed PMC
Gao F, Li M, Wang Z, Shi L, Lou L, Zhou J. Efficacy and safety of gamma knife radiosurgery for meningiomas in patients with neurofibromatosis type 2: a long-term follow-up single-center study. World Neurosurg. 2019;125:e929–e936. PubMed
Minniti G, Amichetti M, Enrici R M. Radiotherapy and radiosurgery for benign skull base meningiomas. Radiat Oncol. 2009;4:42. PubMed PMC
Birckhead B, Sio T T, Pollock B E, Link M J, Laack N N. Gamma knife radiosurgery for neurofibromatosis type 2-associated meningiomas: a 22-year patient series. J Neurooncol. 2016;130(03):553–560. PubMed
Kondziolka D, Mathieu D, Lunsford L Det al.Radiosurgery as definitive management of intracranial meningiomas Neurosurgery 2008620153–58., discussion 58–60 PubMed
DiBiase S J, Kwok Y, Yovino S et al.Factors predicting local tumor control after gamma knife stereotactic radiosurgery for benign intracranial meningiomas. Int J Radiat Oncol Biol Phys. 2004;60(05):1515–1519. PubMed
Flickinger J C, Kondziolka D, Maitz A H, Lunsford L D. Gamma knife radiosurgery of imaging-diagnosed intracranial meningioma. Int J Radiat Oncol Biol Phys. 2003;56(03):801–806. PubMed
Kane A J, Sughrue M E, Rutkowski M J et al.Anatomic location is a risk factor for atypical and malignant meningiomas. Cancer. 2011;117(06):1272–1278. PubMed PMC